Health Law Advisor

On April 30, 2026, the newly constituted National Fraud Enforcement Division (NFED) of the U.S. Department of Justice announced the formation of a West Coast Health Care Fraud Strike Force. This new Strike Force combines the resources of DOJ’s Health Care Fraud Unit (which was recently placed under operational control of NFED, as discussed below) and the U.S. Attorney’s Offices (USAOs) for the Districts of Arizona, Nevada, and the Northern District of California.

[Update: New York Governor Kathy Hochul vetoed S. 929 on December 19, 2025.]

New York State appears poised to become the fourth state to explicitly regulate consumer health data not covered by the federal Health Insurance Portability and Accountability Act (HIPAA). In May of 2023, Washington State enacted the My Health My Data Act; in June of 2023, Connecticut amended its Data Privacy Act; and in March of 2024, Nevada passed Senate Bill 370. In many respects, NY HIPA is broader in scope and effect than its three predecessors.

New York’s S929 (Health Information Privacy Act or NY HIPA), sponsored by state Senator Liz Krueger (D), establishes requirements for communications to individuals regarding the disposition of their health information; and requires written consent or a designated necessary purpose for the processing of such health information. NY HIPA addresses vulnerabilities unaddressed by HIPAA because it applies to a broader range of private companies and protects health information at risk of disclosure through the commercialization of health data.

On June 16, 2023, Nevada enacted Senate Bill 370 (“SB 370”), which imposes broad restrictions on the collection, use, and sale of consumer health data. This law is set to go into effect on March 31, 2024.

On July 2, 2019, New Jersey joined Illinois, Nevada, New Mexico, New York City, and Oklahoma in enacting employment protections for authorized users of medical cannabis. New Jersey’s new medical cannabis law (“Law”), which became effective upon signing by Governor Phil Murphy, amends the state’s Compassionate Use Medical Cannabis Act (“CUMCA”),[1] N.J.S.A. 24:61-2, et seq. Among other measures, the Law prohibits employers from taking an adverse employment action against a current or prospective employee based on the individual’s status as a registered ...

On June 5, 2019, Governor Steve Sisolak of Nevada signed AB 132 (the “Law”), which prohibits employers from declining to hire a prospective employee based on pre-employment marijuana drug tests. On the heels of a new New York City law which prohibits employers from requiring pre-employment drug testing for marijuana and tetrahydrocannabinols (the active ingredient in marijuana), Nevada is now the first state to prohibit employers from using pre-employment drug tests to screen out applicants who use marijuana.

Under the Law, beginning January 1, 2020, employers in Nevada ...

About two weeks ago, the Governor of Nevada signed into law new legislation that removes a number of barriers to the practice of telehealth within the state of Nevada.  Among the most significant changes, the Nevada legislation allows physicians to establish a physician-patient relationship (which is a precondition for prescribing drugs, rendering diagnoses, and performing other medical services) through a telehealth encounter.  In doing so, Nevada joins only a small number of states that have taken this step.  However the Nevada law is significant not only because it allows a ...